Delivery Order SPE2DB22D1017-SPE2DB25FYQLG
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $2,080.53 to AmerisourceBergen Drug Corp for the supply of Prevacid DR 15 mg Solutab UD in quantities of 100 units. This firm fixed price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Prevacid DR 15 mg Solutab UD in quantities of 100 units. This firm fixed-price delivery order has a ceiling value of $1,844.36 and an ultimate completion date of August 29, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,843.20, is for the supply of PREVACID DR 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,502.59 firm fixed-price delivery order is for the supply of PREVACID DR 30 MG SOLUTAB UD 100S, a type of medication. The contract has an ultimate completion date of September 25, 2023. This award is a delivery order issued under AmerisourceBergen's existing Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply PREVACID DR 30 MG SOLUTAB UD 100S. The firm-fixed-price delivery order has a ceiling value of $10,882.32 and an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,541.45, is for the delivery of 4,563,556,981 PREVACID DR 30 MG SOLUTAB UD 100S, a prescription medication. The contract has a period of performance through February 6, 2024 and is a firm fixed-price delivery order. The contract was awarded on February 5, 2024 and was not set aside for any specific business...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of PREVACID DR 30 MG SOLUTAB UD 100S, a pharmaceutical product, with a ceiling value of $1,844.12. The contract is a delivery order and is priced on a firm fixed price basis. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,486.78 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit-dose packaging (100 count). This is a firm fixed price, non-set-aside delivery order with a completion date of September 2, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,305.22 firm fixed price delivery order is for the supply of PREVACID DR 30 MG SOLUTAB UD 100S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,232.16 and covers the delivery of PREVACID DR 30 MG SOLUTAB UD 100S, a prescription medication, through January 7, 2025. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQLGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,738.28 to AmerisourceBergen Drug Corp for the supply of Prevacid DR 30 mg capsules (100 count) on September 10, 2025, with completion scheduled for September 11, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through the DLA's medical supply chain. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and active through December 2026. The parent IDC, designated SPE2DX, functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements through open competition across multiple therapeutic domains positions it as a primary pharmaceutical distributor for Department of Defense medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/10/25 |